This recent article provides an update on Duke University's development of a microchip device that could make cancer remission permanent:
Project lead, Dr. Benjamin Yellen, will sharing more details on his team's progress at the 2014 Next Generation Dx Summit, as part of the Single-Cell Sequencing Track.
Project lead, Dr. Benjamin Yellen, will sharing more details on his team's progress at the 2014 Next Generation Dx Summit, as part of the Single-Cell Sequencing Track.